Paper17517626
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming.
Valmori D and 19 others. Proc Natl Acad Sci U S A, 2007. Cited by 251 papers, by iCite.
Cite this record
ConductScience Library. Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming. Papers, record 17517626. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17517626
- Disease
- cancer699 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies | Major topic |
| Antigens, Neoplasm | Major topic |
| CD8-Positive T-Lymphocytes | Major topic |
| Cross-Priming | Major topic |
| Mannitol | Major topic |
| Membrane Proteins | Major topic |
| Oleic Acids | Major topic |
| Oligodeoxyribonucleotides | Major topic |
| Th1 Cells | Major topic |
| Cancer Vaccines | |
| Epitopes, B-Lymphocyte | |
| Humans | |
| Immunotherapy | |
| Neoplasms | |
| Recombinant Proteins | |
| Vaccination |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| K23 CA125205 | NCI NIH HHS | United States | K23CA125205 | PubMed and NIH |
Source NIH RePORTER
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00299728 | NY-ESO-1 Protein With Montanide and CpG 7909 as Cancer Vaccine in Several Tumors | Results |
Source ClinicalTrials.gov
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10742135 | Monoclonal antibody therapies-a 'constant' threat to cancer. | Nat Med | 2000 | https://conductscience.org/library/papers/10742135 | PubMed |
| 2 | 16034368 | Cancer/testis antigens, gametogenesis and cancer. | Nat Rev Cancer | 2005 | https://conductscience.org/library/papers/16034368 | PubMed |
| 3 | 16984998 | Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16984998 | PubMed |
| 4 | 15696196 | Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909. | J Clin Invest | 2005 | https://conductscience.org/library/papers/15696196 | PubMed |
| 5 | 16541472 | Toll-like receptor stimulation as a third signal required for activation of human naive B cells. | Eur J Immunol | 2006 | https://conductscience.org/library/papers/16541472 | PubMed |
| 6 | 9547346 | A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. | J Exp Med | 1998 | https://conductscience.org/library/papers/9547346 | PubMed |
| 7 | 15994128 | Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responses. | Clin Immunol | 2005 | https://conductscience.org/library/papers/15994128 | PubMed |
| 8 | 16507175 | B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome. | Arthritis Res Ther | 2006 | https://conductscience.org/library/papers/16507175 | PubMed |
| 9 | 11782380 | NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells. | Cancer Res | 2002 | https://conductscience.org/library/papers/11782380 | PubMed |
| 10 | 24443506 | Pillars article: two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999. 401: 708-712. | J Immunol | 2014 | https://conductscience.org/library/papers/24443506 | PubMed |
| 11 | 12445278 | Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. | Immunol Rev | 2002 | https://conductscience.org/library/papers/12445278 | PubMed |
| 12 | 16604075 | Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. | Nat Immunol | 2006 | https://conductscience.org/library/papers/16604075 | PubMed |
| 13 | 9892619 | Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. | J Exp Med | 1999 | https://conductscience.org/library/papers/9892619 | PubMed |
| 14 | 15252201 | Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15252201 | PubMed |
| 15 | 15546948 | Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery. | Blood | 2005 | https://conductscience.org/library/papers/15546948 | PubMed |
| 16 | 11861616 | CpG motifs in bacterial DNA and their immune effects. | Annu Rev Immunol | 2002 | https://conductscience.org/library/papers/11861616 | PubMed |
| 17 | 7872156 | Molecular basis of Fc receptor function. | Adv Immunol | 1994 | https://conductscience.org/library/papers/7872156 | PubMed |
| 18 | 9933083 | Cellular requirements for the monoclonal antibody-mediated eradication of an established solid tumor. | Eur J Immunol | 1999 | https://conductscience.org/library/papers/9933083 | PubMed |
| 19 | 7595233 | Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein. | J Exp Med | 1995 | https://conductscience.org/library/papers/7595233 | PubMed |
| 20 | 11429607 | Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. | Nature | 2001 | https://conductscience.org/library/papers/11429607 | PubMed |
Cited by144
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 251 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42698927 | Mechanistic biomarkers for cancer vaccine development: from cancer cell biology to neoantigen-guided precision immunotherapy. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42698927 | PubMed |
| 42531334 | DNA oligonucleotides block viral entry of SARS-CoV-2 Omicron variants. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/42531334 | PubMed |
| 42406997 | TLR9 Agonists Potentiate Adoptive T-cell Therapy in Cancer through a B-cell-CD2 Costimulatory Axis. | Cancer Res | 2026 | https://conductscience.org/library/papers/42406997 | PubMed |
| 40379970 | Recent advances in therapeutic cancer vaccines. | Nat Rev Cancer | 2025 | https://conductscience.org/library/papers/40379970 | PubMed |
| 40132910 | mTOR inhibition modulates vaccine-induced immune responses to generate memory T cells in patients with solid tumors. | J Immunother Cancer | 2025 | https://conductscience.org/library/papers/40132910 | PubMed |
| 39275923 | NY-ESO-1 antigen: A promising frontier in cancer immunotherapy. | Clin Transl Med | 2024 | https://conductscience.org/library/papers/39275923 | PubMed |
| 38797949 | An Open-Label Study of Subcutaneous CpG Oligodeoxynucleotide (PF03512676) in Combination with Trastuzumab in Patients with Metastatic HER2+ Breast Cancer. | Cancer Control | 2024 | https://conductscience.org/library/papers/38797949 | PubMed |
| 37936697 | Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy. | Front Immunol | 2023 | https://conductscience.org/library/papers/37936697 | PubMed |
| 37731507 | Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatment. | Front Immunol | 2023 | https://conductscience.org/library/papers/37731507 | PubMed |
| 37584947 | Th1-polarized MtrE-based gonococcal vaccines display prophylactic and therapeutic efficacy. | Emerg Microbes Infect | 2023 | https://conductscience.org/library/papers/37584947 | PubMed |
| 36560420 | Recent Advances in Cancer Vaccines: Challenges, Achievements, and Futuristic Prospects. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/36560420 | PubMed |
| 35806328 | Dendritic Cell-Based Immunotherapy in Hot and Cold Tumors. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35806328 | PubMed |
| 35737089 | Potent anti-tumor immune response and tumor growth inhibition induced by HER2 subdomain fusion protein in a mouse tumor model. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/35737089 | PubMed |
| 35651800 | Fueling Cancer Vaccines to Improve T Cell-Mediated Antitumor Immunity. | Front Oncol | 2022 | https://conductscience.org/library/papers/35651800 | PubMed |
| 35303904 | Cancer vaccines as promising immuno-therapeutics: platforms and current progress. | J Hematol Oncol | 2022 | https://conductscience.org/library/papers/35303904 | PubMed |
| 35217574 | Peptidic microarchitecture-trapped tumor vaccine combined with immune checkpoint inhibitor or PI3Kγ inhibitor can enhance immunogenicity and eradicate tumors. | J Immunother Cancer | 2022 | https://conductscience.org/library/papers/35217574 | PubMed |
| 35017148 | B cells imprint adoptively transferred CD8+ T cells with enhanced tumor immunity. | J Immunother Cancer | 2022 | https://conductscience.org/library/papers/35017148 | PubMed |
| 34971473 | Cancer immunotherapy using artificial adjuvant vector cells to deliver NY-ESO-1 antigen to dendritic cells in situ. | Cancer Sci | 2022 | https://conductscience.org/library/papers/34971473 | PubMed |
| 34386424 | The Clinical Application of Neoantigens in Esophageal Cancer. | Front Oncol | 2021 | https://conductscience.org/library/papers/34386424 | PubMed |
| 34385817 | CpG-Based Nanovaccines for Cancer Immunotherapy. | Int J Nanomedicine | 2021 | https://conductscience.org/library/papers/34385817 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| CTAG1A | 246100 | PubTator's text mining | https://conductscience.org/library/genes/246100 | NCBI Gene |
Drugs2
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| AGATOLIMOD SODIUM | CHEMBL2103793 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL2103793 | ChEMBL |
| INCOMPLETE FREUND'S ADJUVANT | CHEMBL4650400 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL4650400 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17517626
GET https://conductscience.org/api/papers/v1/17517626/references?page=2